Login

Otenabant

CAT:
804-HY-10871-02
Size:
10 mM / 1 mL
Price:
Ask
For price, please contact [email protected]
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Otenabant - image 1

Otenabant

  • CAS Number: 686344-29-6
  • UNSPSC Description: Otenabant is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor.
  • Target Antigen: Cannabinoid Receptor
  • Type: Reference compound
  • Related Pathways: GPCR/G Protein;Neuronal Signaling
  • Applications: Metabolism-protein/nucleotide metabolism
  • Field of Research: Metabolic Disease
  • Assay Protocol: https://www.medchemexpress.com/Otenabant.html
  • Purity: 99.23
  • Solubility: DMSO : 100 mg/mL (ultrasonic)
  • Smiles: ClC1=CC=CC=C1C2=NC3=C(N4CCC(NCC)(C(N)=O)CC4)N=CN=C3N2C5=CC=C(Cl)C=C5
  • Molecular Weight: 510.42
  • References & Citations: [1]John R. Hadcock, et al. In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB1 receptor antagonist for the management of obesity. Biochemical and Biophysical Research Communications, 2010; 394;366-371.|[2]Griffith DA, et al. Discovery of 1-[9-(4-chlorophenyl) -8-(2-chlorophenyl)- 9H-purin-6-yl] -4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist. JMedChem. 2009 ;5
  • Shipping Conditions: Room Temperature
  • Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information: Phase 3